MAPK1 and breast cancer: Overall, our study first demonstrated that the axis of miR-543/UBE2T in the development of breast cancer by inhibiting the ERK/MAPK pathway, which indicated that miR-543, UBE2T, and their regulation of the ERK/MAPK pathway, which could have prognostic and diagnostic values for patients with breast cancer.